-
Covance Announces $250M Share Buyback
Wednesday, September 29, 2010 - 7:20am | 113After the close of the market, Covance (NYSE: CVD) announced a new $250 million share repurchase program. This authorization is in addition to the ~800K shares remaining under the company's 2007 share repurchase program and represents ~10% of the company's current shares outstanding. Deutsche...
-
Goldman Sachs Still Neutral On Covance After Buyback (CVD)
Wednesday, September 29, 2010 - 6:57am | 135Goldman Sachs still has a Neutral rating on Covance Inc. (NYSE: CVD) after the company announced a new buyback program worth $250 million. In the research report, Goldman Sachs writes, "Today Covance announced that its board of directors has authorized a new share repurchase program for up to $250...
-
Covance Board Authorizes $250 Million Buyback
Tuesday, September 28, 2010 - 4:12pm | 107Covance Inc. (NYSE: CVD) said today that its Board of Directors has authorized the repurchase of up to $250 million of its outstanding common stock. This authorization is in addition to the approximately 800,000 shares remaining under the repurchase authorization announced in 2007 and currently...
-
Benzinga's Top Downgrades (AFFX, ESRX, NOK, ZMH)
Monday, September 27, 2010 - 7:44am | 146Affymetrix Inc (NASDAQ: AFFX) was downgraded by Piper Jaffray from “overweight” to "neutral." AFFX's shares closed at $4.82 on Friday. Affymetrix's quarterly earnings plunged 175.60% y/y. Goldman downgraded Express Scripts Inc (NASDAQ: ESRX) from "buy" to "neutral." ESRX's shares closed at $49.60...
-
Piper Jaffray Still Overweight On EXEL
Monday, September 27, 2010 - 7:27am | 113Piper Jaffray has issued a research report for Exelixis, Inc (NASDAQ: EXEL), stating: "Wholly-owned XL184 is a potent MET, RET and VEGFR2 inhibitor. We see a broad development plan for XL184 with opportunities in multiple tumor types. We look for 1st potential approval in metastatic thyroid cancer...
-
Looking Back & Looking Ahead 09-24-2010
Friday, September 24, 2010 - 6:45pm | 835Cusick's Corner Trading has been volatile over the past few sessions, but the week ended on a positive note as investors reacted to better-than-expected economic data and the Fed announcement from earlier in the week. The latest Fed statement pledged that the Fed may utilize QE if necessary to...
-
Benzinga's Top Pre-Market NASDAQ Gainers (BBBY, PSDV, NVDA, AKAM)
Thursday, September 23, 2010 - 9:25am | 126Bed Bath & Beyond Inc (NASDAQ: BBBY) rose 4.76% to $44.05 in the pre-market session. BBBY had reported upbeat results for the second quarter yesterday. pSivida Corp (NASDAQ: PSDV) added 2.34% to $4.38 in the pre-market session. PSDV swung to Q4 profits. NVIDIA Corporation (NASDAQ: NVDA) soared...
-
The Daily Long and Short Setup
Wednesday, September 22, 2010 - 11:22am | 141Market is showing some signs of weakness, and so far today has managed to maintain it with out any significant rally. If we see further selling today, I'll probably look to pick up a long position. BRKR (shown below) is very intriguing. LONG: Bruker Corp. (BRKR) Read more...
-
Traders Worried That AMAG Pharma Will Fall (AMAG)
Wednesday, September 22, 2010 - 11:16am | 174Shares of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) are higher on the session by 1.95%, currently trading at $20.35. The stock has been moving largely lower over the past two months, off from a recent high near $40.00. Options traders do not see the slide abating anytime soon. A short while ago...
-
The Architecture Billing Index (A Leading Indicator) Improves in Aug. and In 6 Out of the Last 7 Months
Wednesday, September 22, 2010 - 8:59am | 446The American Institute of Architects (AIA) just released its monthly Architecture Billings Index (ABI) for August, which improved to 48.2 last month compared to 47.9 in July, and was the sixth monthly increase during the last seven months of the leading economic indicator for construction activity...
-
Sequenom Files $150 Million Shelf Offering (SQNM)
Tuesday, September 21, 2010 - 5:33pm | 132Shares of Sequenom, Inc. (NASDAQ: SQNM) are trading lower in the after-hours by 2.84%, trading at $6.85 after the company reported that it filled a $150 million mixed securities shelf offering. SQNM closed the regular session at $7.05, higher by 0.57%. Sequenom, Inc. is a diagnostic testing and...
-
Genetic Gains? Affymetrix and Illumina (AFFX, ILMN)
Tuesday, September 21, 2010 - 11:36am | 118"Two of our long-standing buy recommendations are involved in selling products and services for the genetic research market: Affymetrix (NASDAQ: AFFX) and Illumina (NASDAQ: ILMN)," notes biotech and growth stock specialist Nate Pile. The editor of Nate's Notes explains, "In a nutshell, both of...
-
Benzinga's Top Pre-Market NASDAQ Losers (AMAG, GXDX, CHBT, TCAP)
Tuesday, September 21, 2010 - 9:10am | 125AMAG Pharmaceuticals Inc (NASDAQ: AMAG) dipped 11.03% to $20.90 in the pre-market session. AMAG's trailing-twelve-month operating margin is -182.31%. Genoptix Inc (NASDAQ: GXDX) lost 10.31% to $14.70 in the pre-market session. GXDX's quarterly earnings dipped 28.80% y/y. China-Biotics Inc (NASDAQ:...
-
A Peek Into The Market Before The Trading Starts
Tuesday, September 21, 2010 - 8:43am | 472Pre-open movers US futures were mixed as the investors moved to the sidelines, awaiting the Federal Reserve decision on the monetary policy, today. Futures on the Dow Jones Industrial Average rose 7 points to 10,678 and S&P 500 futures moved down 1.20 points to 1,135. Nasdaq 100 futures gained...
-
Zacks #5 Rank Additions for Tuesday - Tale of the Tape
Tuesday, September 21, 2010 - 8:39am | 345Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Acorn Intl Inc (ATV) Compass Minerals Intl Inc (CMP) Covance Inc (CVD) Dress Barn Inc (DBRN) Encore Energy Partners LP (ENP) View the entire Zacks #5 Rank List. ACORN INTL-ADR (ATV): Free Stock Analysis Report COMPASS...